摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3-(4-chlorophenylamino)-1H-pyrazol-5-yl)(3-methylpiperidin-1-yl)methanone | 1204316-93-7

中文名称
——
中文别名
——
英文名称
(3-(4-chlorophenylamino)-1H-pyrazol-5-yl)(3-methylpiperidin-1-yl)methanone
英文别名
[3-(4-chloroanilino)-1H-pyrazol-5-yl]-(3-methylpiperidin-1-yl)methanone
(3-(4-chlorophenylamino)-1H-pyrazol-5-yl)(3-methylpiperidin-1-yl)methanone化学式
CAS
1204316-93-7
化学式
C16H19ClN4O
mdl
——
分子量
318.806
InChiKey
RHVYRXNLGSDCED-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    22
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    61
  • 氢给体数:
    2
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    5-(4-chlorophenylamino)-2H-pyrazole-3-carboxylic acid 、 3-甲基哌啶N,N-二异丙基乙胺 、 Methanaminium,N-[(dimethylamino)(3H-1,2,3-triazolo[4,5-b]pyridin-3-yloxy)methylene]-N-methyl-, hexafluorophosphate(1-) 作用下, 以 乙二醇二甲醚 为溶剂, 反应 6.0h, 生成 (3-(4-chlorophenylamino)-1H-pyrazol-5-yl)(3-methylpiperidin-1-yl)methanone
    参考文献:
    名称:
    Piperidyl amides as novel, potent and orally active mGlu5 receptor antagonists with anxiolytic-like activity
    摘要:
    High throughput screening led to the identification of nicotinamide derivative 2 as a structurally novel mGluR5 antagonist. Optimization of the modular scaffold led to the discovery of 16m, a compound with high affinity for mGluR5 and excellent selectivity over other glutamate receptors. Compound 16m exhibits a favorable PK profile in rats, robust anxiolytic-like effects in three different animal models of fear and anxiety, as well as a good PK/PD correlation. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.11.001
点击查看最新优质反应信息

文献信息

  • Piperidyl amides as novel, potent and orally active mGlu5 receptor antagonists with anxiolytic-like activity
    作者:Carsten Spanka、Ralf Glatthar、Sandrine Desrayaud、Markus Fendt、David Orain、Thomas Troxler、Ivo Vranesic
    DOI:10.1016/j.bmcl.2009.11.001
    日期:2010.1
    High throughput screening led to the identification of nicotinamide derivative 2 as a structurally novel mGluR5 antagonist. Optimization of the modular scaffold led to the discovery of 16m, a compound with high affinity for mGluR5 and excellent selectivity over other glutamate receptors. Compound 16m exhibits a favorable PK profile in rats, robust anxiolytic-like effects in three different animal models of fear and anxiety, as well as a good PK/PD correlation. (C) 2009 Elsevier Ltd. All rights reserved.
查看更多